Reflecting Compliance Architects^® strong, demonstrated expertise in data integrity risk identification and resolution within the pharmaceutical and related industries, Jack Garvey, Founder and Chief Executive Officer of Compliance Architects^® was cited recently by Event Driven, an investment news and analysis subscription product of Reorg Research.  Jack provided insight and analysis to Event Driven on the impact of receipt of an FDA 483 by Akorn Pharmaceuticals to the proposed/pending merger of Akorn into Fresenius Kabi.   Jack helped the Event Driven staff understand the legal and regulatory background and drivers of FDA 483s, Warning Letters, and data integrity concerns, helping them to assess and communicate possible impacts of these circumstances to the investment community.

Event Driven’s article incorporating Jack’s expertise can be found here:  Event Driven Article